|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.03 USD | -0.30% |
|
+2.40% | -10.70% |
| May. 02 | Avanos Medical to Seek M&A Opportunities | CI |
| May. 02 | Transcript : Avanos Medical, Inc., Q1 2024 Earnings Call, May 02, 2024 |
Avanos Medical, Inc. provided earnings outlook for the full year 2022. For the period, the company is modifying its guidance for 2022 net sales to between $815 million and $835 million, which assumes organic growth between 1% to 4%. Additionally, confirming gross profit margins to be between 55% to 57%.
Diluted earnings per share (GAAP) between $0.95 to $1.25.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.70% | 867M | |
| -4.98% | 181B | |
| +2.84% | 112B | |
| -2.68% | 67.92B | |
| +4.53% | 50.1B | |
| +8.00% | 44.27B | |
| +9.39% | 40.41B | |
| +25.30% | 31.95B | |
| -0.17% | 25.82B | |
| +17.27% | 25.29B |
AVANOS MEDICAL, INC. 
